GABAA
|
Inhibition of neuronal activity/iPSP |
Type A (subtype not specified) |
Implicit from in vivo study. |
Keeps spinally projecting neurones tonically inhibited |
Martin et al., 1991; Martin and Haywood, 1993
|
|
|
|
Patch-clamp electrophysiology |
|
Li et al., 2002, 2004b; Zaki and Barrett-Jolley, 2002; Womack et al., 2006
|
|
|
GABAA α2-subunit |
Immunohistochemistry |
Also seen specifically in spinally projecting neurones |
Fritschy and Mohler, 1995; Nunn et al., 2011
|
|
|
α5-subunit |
Immunohistochemistry |
Decreased in hypertension |
Cullinan, 2000 |
|
|
α2, β1, and β3 subunits |
qPCR |
Especially in CRH positive neurones |
Wang et al., 2009 |
GABAB
|
Inhibition of neuronal activity |
– |
Patch-clamp electrophysiology (post synaptic potentials). |
Further inhibition of spinally-projecting neurones |
Chen and Pan, 2006; Wang et al., 2009
|
Glutamate |
Excitation/ePSPs |
NMDA, AMPA |
Patch-clamp |
Activation of spinally-projecting neurones |
Cui et al., 2001 |
|
Excitation/ePSPs |
GluR5; Kainate (KAR) |
In situ hybridization and immunohistochemical plus a cFos study/pharmacology |
|
Evanson et al., 2009 |
|